Empagliflozin improves renal ischemia-reperfusion injury by reducing inflammation and enhancing mitochondrial fusion through AMPK-OPA1 pathway promotion.
Cell Mol Biol Lett
; 28(1): 42, 2023 May 18.
Article
in En
| MEDLINE
| ID: mdl-37202752
Key words
Full text:
1
Collection:
01-internacional
Health context:
6_ODS3_enfermedades_notrasmisibles
Database:
MEDLINE
Main subject:
Reperfusion Injury
/
Mitochondrial Dynamics
Limits:
Animals
/
Humans
Language:
En
Journal:
Cell Mol Biol Lett
Year:
2023
Document type:
Article